Pharmacy |
| ||
|
TRAVATAN Generic Travoprost |
|
| ||
Home » Prescription Drugs 16 » TRAVATAN Generic Travoprost Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Treatment for: Glaucoma and Ocular Hypertension. The U.S. Food and Drug Administration (FDA) has approved Travatan (travoprost ophthalmic solution) 0.004% for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are intolerant of or insufficiently responsive to other intraocular pressure lowering medications. Travatan indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive to another IOP lowering medication. Buy TRAVATAN Generic Travoprost and other Prescription Drugs 16 products online at Medstore. 3592
About TRAVATAN Generic Travoprost: Product Type: Prescription Drugs 16 TRAVATAN ( Generic Travoprost ) TRAVATAN (Generic Travoprost) Generic Travoprost 0.004% Drops 2.5ml 1 x Bottle Generic Travoprost TRAVATAN
View more Prescription Drugs 16 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
